This strongly suggests a need for inhibition of the corresponding RTKs in the specific subgroups with low INPP5D expression, which could compensate for the loss of SHIP1 inhibition of the different signaling cascades in T-ALL cells (PI3K/AKT, MAPK, PLC). The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.